<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="generator" content="pandoc">
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name="author" content="Helmut Schütz">
<meta name="date" content="2019-10-21">
<link rel="icon" href="data:image/x-icon;base64,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" type="image/x-icon">
<title>PowerTOST • Main Vignette</title>
<style>code{white-space:pre}</style>
<style data-origin="pandoc">
a.sourceLine{display:inline-block;line-height:1.25}
a.sourceLine{pointer-events:none;color:inherit;text-decoration:inherit}
a.sourceLine:empty{height:1.2em}
.sourceCode{overflow:visible}
code.sourceCode{white-space:pre;position:relative}
div.sourceCode{margin:1em 0}
pre.sourceCode{margin:0}
@media screen{
div.sourceCode {overflow:auto}
}
@media print {
code.sourceCode{white-space:pre-wrap}
a.sourceLine{text-indent: -1em; padding-left: 1em}
}
pre.numberSource a.sourceLine
  {position: relative; left: -4em}
pre.numberSource a.sourceLine::before
  {content:attr(title);
    position:relative;left:-1em;text-align:right;vertical-align:baseline;
    border:none;pointer-events:all;display:inline-block;
    -webkit-touch-callout:none;-webkit-user-select:none;
    -khtml-user-select:none;-moz-user-select:none;
    -ms-user-select:none;user-select:none;
    padding:0 4px;width:4em;
    color:#aaaaaa}
pre.numberSource {margin-left:3em;border-left:1px solid #aaaaaa;padding-left:4px}
div.sourceCode
  { }
@media screen {
a.sourceLine::before{text-decoration:underline}
}
code span.al {color:#ff0000; font-weight:bold} /* Alert */
code span.an {color:#60a0b0; font-weight:bold; font-style:italic} /* Annotation */
code span.at {color:#7d9029} /* Attribute */
code span.bn {color:#40a070} /* BaseN */
code span.bu {} /* BuiltIn */
code span.cf {color:#007020; font-weight:bold} /* ControlFlow */
code span.ch {color:#4070a0} /* Char */
code span.cn {color:#880000} /* Constant */
code span.co {color:#60a0b0; font-style:italic} /* Comment */
code span.cv {color:#60a0b0; font-weight:bold; font-style:italic} /* CommentVar */
code span.do {color:#ba2121; font-style:italic} /* Documentation */
code span.dt {color:#902000} /* DataType */
code span.dv {color:#40a070} /* DecVal */
code span.er {color:#ff0000; font-weight:bold} /* Error */
code span.ex {} /* Extension */
code span.fl {color:#40a070} /* Float */
code span.fu {color:#06287e} /* Function */
code span.im {} /* Import */
code span.in {color:#60a0b0; font-weight:bold; font-style:italic} /* Information */
code span.kw {color:#007020; font-weight:bold} /* Keyword */
code span.op {color:#666666} /* Operator */
code span.ot {color:#007020} /* Other */
code span.pp {color:#bc7a00} /* Preprocessor */
code span.sc {color:#4070a0} /* SpecialChar */
code span.ss {color:#bb6688} /* SpecialString */
code span.st {color:#4070a0} /* String */
code span.va {color:#19177c} /* Variable */
code span.vs {color:#4070a0} /* VerbatimString */
code span.wa {color:#60a0b0; font-weight:bold; font-style: italic} /* Warning */
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try {var rules = sheets[i].cssRules} catch (e) {continue}
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>
<style>body{background-color:#fff;margin:1em auto;max-width:700px;overflow:visible;padding-left:2em;padding-right:2em;font-size:14px;line-height:1.35;hyphens:auto;font-family:"Open Sans","Helvetica Neue",Helvetica,Arial,sans-serif}#header{text-align:center}#TOC{clear:both;margin:0 3em;padding:4px;width:auto;border:1px solid #ccc;border-radius:5px;background-color:#fbfbfb;font-size:13px;line-height:1.2em}#TOC .toctitle{font-weight:bold;font-size:15px;margin-left:5px}#TOC ul{padding-left:40px;margin:5px auto 5px -1.5em}#TOC ul ul{margin-left:-2em}#TOC li{list-style-type:none;line-height:16px}table{margin:1em auto;border-width:1px;border-color:#ddd;border-style:outset;border-collapse:collapse}table th{border-width:2px;padding:5px;border-style:inset}table td{border-width:1px;border-style:inset;line-height:18px;padding:5px 5px}table, table th, table td{border-left-style:none;border-right-style:none}table thead, table .even{background-color:#f7f7f7}p{margin:0.5em 0}sup, sub{position:relative;vertical-align:baseline;top:-0.4em}sub{top:0.4em}blockquote{background-color:#fffff6;padding:0.25em 0.75em}hr{border-style:solid;border:none;border-top:1px solid #777;margin:28px 0}dl{margin-left:0}dl dd{margin-bottom:13px;margin-left:13px}dl dt{font-weight:700}ul{margin-top:0}ul li{list-style:circle outside}ul ul{margin-bottom:0}pre, code{background-color:#f7f7f7;border-radius:3px;color:#333;white-space:pre-wrap}pre{border-radius:3px;margin:5px 0 10px 0;padding:10px}pre:not([class]){background-color:#f7f7f7}code{font-size:85%;font-family:Consolas,Monaco,'Lucida Console','Courier New','Courier',monospace}p > code,li > code{padding:2px 0}figure,.caption{text-align:center}img{display:block;margin:0 auto 0 auto;background-color:#FFF;padding:2px;border-radius:5px;border:1px solid #CCC}h1{margin-top:0;padding-top:10px;padding-bottom:4px;;line-height:30px;letter-spacing:.5px;border-bottom:3px solid #f7f7f7;font-size:175%;hyphens:none}.title{margin-top:1.5em}h2{border-bottom:2px solid #f7f7f7;padding-top:10px;padding-bottom:2px;font-size:145%}h3{border-bottom:1px solid #f7f7f7;padding-top:10px;font-size:120%}h4{margin-left:8px;font-size:110%}.author{font-size:91%;margin-left:0;margin-bottom:0;font-style:normal}h5, h6{border-bottom:1px solid #ccc;font-size:105%}a{color:#0033dd;text-decoration:none}a:hover{color:#6666ff}a:visited{color:#800080}a:visited:hover{color:#BB00BB}a[href^="http:"]{color:#696969;border-bottom:1px dotted #000}a[href^="https:"]{border-bottom:1px dotted #000;color:#696969}code > .kw{color:#555;font-weight:700} code > .dt{color:#902000} code > .dv{color:#40a070} code > .bn{color:#d14} code > .fl{color:#d14} code > .ch{color:#d14} code > .st{color:#d14} code > .co{color:#888888;font-style:italic} code > .ot{color:#007020} code > .al{color:#f00;font-weight:700} code > .fu{color:#900;font-weight:700}  code > .er{color:#a61717;background-color:#e3d2d2} .top{display:inline;position:fixed;bottom:0;right:0;padding:0;font-size:108px}.top img{border:none}a.toplink:link{background-image:url(data:image/png;base64,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);background-repeat:no-repeat;text-decoration:none;background-color:transparent;opacity:.6;filter:alpha(opacity=60);background-position:bottom 7px right;background-size:contain}a.toplink:hover,a.toplink:active{text-decoration:none;background-color:transparent;opacity:.4;filter:alpha(opacity=40);background-position:bottom 7px right;background-size:contain}code span.co{font-style:normal}#nav{position:absolute;top:0;float:left;background-color:#084262;border:none}#nav ul{width:100%;list-style-type:none;text-align:center;color:#fff;font-size:.75em;letter-spacing:2px;font-weight:700;margin:0;padding:0}#nav ul li{display:inline}#nav ul li a,#nav ul li span{color:#fff;background-color:#084262;text-decoration:none;float:left;border-right:1px solid #7394B4;cursor:pointer;padding:.5em 11.5px}#nav ul li a:hover,#nav ul li span{color:#fff;background-color:#257B9D}@media print{#nav,#TOC,#TOC .toctitle,#TOC ul,#TOC ul ul,#TOC li{display:none}}</style>
</head>
<body>
<h1 class="title toc-ignore">PowerTOST • Main Vignette</h1>
<div id="TOC">
<ul>
<li><a href="#introduction">Introduction</a></li>
<li><a href="#abbreviations-definition-of-terms-models">Abbreviations, Definition of Terms, Models</a></li>
<li><a href="#installation">Installation</a></li>
<li><a href="#contributors">Contributors</a></li>
<li><a href="#session-information">Session Information</a></li>
<li><a href="#license">License</a></li>
</ul>
</div>
<div class="top"><a class="toplink" href="#nav" title="⇑ top">&nbsp;</a></div>
<div id="nav">
<ul>
<li><span title="» You are here «">Main Vignette</span></li>
<li><a href="ABE.html" title="Average Bioequivalence">ABE</a></li>
<li><a href="RSABE.html" title="Reference-scaled Average Bioequivalence">RSABE</a></li>
<li><a href="NI.html">Non-Inferiority</a></li>
<li><a href="DP.html">Dose-Proportionality</a></li>
<li><a href="PA.html">Power Analysis</a></li>
</ul>
</div>
<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>The package contains functions to calculate power and estimate sample size for various study designs used in (not only bio-) equivalence studies. Power and sample size can be obtained based on different methods, amongst them prominently the TOST procedure (two one-sided <em>t</em>-tests).<br>
Version 1.4.8.9000 built 2019-10-21 with R 3.6.1.</p>
<p>For an overview of supported designs, methods, and defaults together with some basic examples see</p>
<ul>
<li><a href="https://cran.r-project.org/package=PowerTOST/readme/README.html">README</a> of the released version on CRAN;</li>
<li><a href="https://github.com/Detlew/PowerTOST/blob/master/README.md">README</a> of the development version on GitHub.</li>
</ul>
<p>More details and examples in the vignettes accessible via the top-menu and the <a href="https://cran.r-project.org/package=PowerTOST/PowerTOST.pdf" title="PDF">online manual</a> of all functions.</p>
</div>
<div id="abbreviations-definition-of-terms-models" class="section level1">
<h1>Abbreviations, Definition of Terms, Models</h1>
<dl>
<dt>2×2×2</dt>
<dd>Crossover design with 2 treatments, 2 sequences, and 2 periods. In the literature also TR | RT or AB | AB. In the functions <code>2x2x2</code> or short <code>2x2</code>.
</dd>
<dt>2x2x3, 2x2x4</dt>
<dd>Full replicate designs with 2 treatments, 2 sequences, and 3 or 4 periods. Both T and R are administered twice to ½ of the subjects.
</dd>
<dt>2×3×3</dt>
<dd>Partial (or semi-) replicate design with 2 treatments, 3 sequences, and 3 periods. R is administered to all subjects twice and T once. Popular (though not optimal) is TRR|RTR|RRT.
</dd>
<dt>2×4×2</dt>
<dd>Full replicate design with 2 treatments, 4 sequences, and 2 periods (Balaam’s design). TR|RT|TT|RR; not optimal due to poor power characteristics.
</dd>
<dt>2×4×4</dt>
<dd>Full replicate designs with 2 treatments, 4 sequences, and 4 periods (TRTR|RTRT|TRRT|RTTR or TRTR|RTRT|TTRR|RRTT). This design should be avoided due to confounding.
</dd>
<dt>3×3, 3×6×3</dt>
<dd>Higher-order crossover designs with 3 treatments, 3 or 6 sequences, and 3 periods (Latin Square or a Williams’ design). In the functions <code>3x3</code> and <code>3x6x3</code>. Both have the same degrees of freedom (2<em>n</em>–4) in the convential approach and therefore, require the same number of subjects.
</dd>
<dt>4×4</dt>
<dd>Higher-order crossover design with 4 treatments, 4 sequences, and 4 periods (Latin Square or a Williams’ design).
</dd>
<dt><span id="abe">ABE</span></dt>
<dd>Average Bioequivalence with <em>fixed</em> limits based on a clinically not relevant difference <small><span class="math inline">\(\Delta\)</span></small>. The common <small><span class="math inline">\(\Delta\)</span></small> 0.20 leads to <small><span class="math inline">\(\theta_1=1-\Delta,\:\theta_2=1/(1-\Delta)\)</span></small> or 80.00–125.00%. For <a href="#ntid">NTIDs</a> (<span title="European Medicines Agency">EMA</span> and other jurisdicions) <small><span class="math inline">\(\Delta\)</span></small> 0.10 (90.00–111.11%). For C<sub>max</sub> (Russian Federation, <span title="Eurasian Economic Union">EEU</span>, <span title="Gulf Cooperation Council">GCC</span>) <small><span class="math inline">\(\Delta\)</span></small> 0.25 (75.00–133.33%).<small><span class="math display">\[H_0:\mu_T/\mu_R\notin \left [ \theta_1,\theta_2 \right ]\:vs\:H_1:\theta_1&lt;\mu_T/\mu_R&lt;\theta_2\]</span></small>
</dd>
<dt><span id="abel">ABEL</span></dt>
<dd>Average Bioequivalence with <em>expanding</em> limits (see also <strong><em><a href="#LU">L, U</a></em></strong>). Same model like for <a href="#abe">ABE</a> but <small><span class="math inline">\(\theta_1,\theta_2\)</span></small> are based on the <em>CV<sub>wR</sub></em> observed in the study.
</dd>
<dt><span class="math inline">\(\alpha\)</span></dt>
<dd>Nominal level of the test. In tests for equivalence commonly 0.05 (except for the ratio of two means with normality on original scale based on Fieller’s (‘fiducial’) confidence interval in function <code>sampleN.RatioF()</code> and for non-inferiority/-superiority in function <code>sampleN.noninf()</code>, where it is 0.025). In the functions <code>alpha</code>.
</dd>
<dt><span class="math inline">\(\beta\)</span></dt>
<dd>Probability that the Null-hypothesis of inequivalence is <em>falsely not</em> rejected. Also the type II error or producer’s risk, where <small><span class="math inline">\(\beta=1-\pi\)</span></small>.
</dd>
<dt><span class="math inline">\(\beta_0\)</span></dt>
<dd>Assumed or true slope of the (linearized) power model of dose-proportionality <small><span class="math inline">\(x=\alpha\cdot dose^\beta,\:log(x)=\alpha+\beta\cdot log(dose)\)</span></small>. Argument <code>beta0</code>.
</dd>
<dt>CV</dt>
<dd><dl>
<dt>Coefficient of variation</dt>
<dd>Calculated from the residual error of the model of log-transformed data as <small><span class="math inline">\(CV=\sqrt{e^{\sigma^2}+1}\)</span></small>.
<ul>
<li>
In crossover designs the intra- (between-) subject CV. Argument <code>CV</code>.
</li>
<li>
In parallel designs the total (pooled) CV. Argument <code>CV</code>.
</li>
<li>
In replicate designs the intra-subject CV (assuming homoscedasticity, argument <code>CV</code>). If heteroscedasticity is assumed, <code>CV</code> has to given as a vector with two elements <code>CV=c(x, y)</code> where <code>CV[1]</code> is <em>CV<sub>wT</sub></em> and <code>CV[2]</code> is <em>CV<sub>wR</sub></em>.
</li>
</ul>
</dd>
</dl>
</dd>
<dt>CV<sub>b</sub></dt>
<dd>Inter- (between-) subject coefficient of variation. Argument <code>CVb</code> is required in function <code>sampleN.RatioF()</code> and in function <code>sampleN.dp()</code> if <code>design=&quot;IBD&quot;</code> (incomplete block design).
</dd>
<dt><span id="CVcap">CV<sub>cap</sub></span></dt>
<dd>Upper cap in <a href="#abel">ABEL</a>. If <em>CV<sub>wR</sub></em> &gt; CV<sub>cap</sub>, expanding is based on CV<sub>cap</sub> (and not on <em>CV<sub>wR</sub></em>). In all jurisdictions 50%, except for Health Canada where CV<sub>cap</sub> ≈57.4%.
</dd>
<dt>CV<sub>switch</sub></dt>
<dd>Switching coefficient of variation in reference-scaling. Only above this value reference-scaling is acceptable. For highly variable drugs / drug products 30% (<em>CV</em><sub>0</sub> 0.30, <em>s</em><sub>0</sub> 0.294).
</dd>
<dt><span id="Delta"><span class="math inline">\(\Delta\)</span></span></dt>
<dd>Clinically not relevant difference. Commonly 0.20. For <a href="#ntid">NTIDs</a> (<span title="European Medicines Agency">EMA</span> and other jurisdicions) 0.10, for C<sub>max</sub> (Russian Federation, <span title="Eurasian Economic Union">EEU</span>, <span title="Gulf Cooperation Council">GCC</span>) 0.25.
</dd>
<dt>HVD(P)</dt>
<dd>Highly variable drug (product); commonly defined with an intra-subject <em>CV</em> of ≥30%. HVDs exhibit highly variable clearances (<em>CV</em> ≥30% if administered as a solution), whereas HVDPs may additionally – or solely – show highly variable absorption. HVDP(s) generally are ones with a flat dose-response curve.
</dd>
<dt><span id="k"><em>k</em></span></dt>
<dd><dl>
<dt>Regulatory constant <span style="font-weight:normal">(also <small><span class="math inline">\(\theta_s\)</span></small>)</span></dt>
<dd><p><strong><a href="#abel">ABEL</a></strong>: Based on the switching coefficient of variation <small><span class="math inline">\(CV_0=30\%\)</span></small>. <small><span class="math inline">\(k=log(1.25)/\sqrt{log(CV_{0}^{2}+1)}\approx 0.760\)</span></small>.</p>
</dd>
<dd><strong><a href="#rsabe">RSABE</a></strong>: Based on the switching standard deviation <small><span class="math inline">\(s_0=0.25\)</span></small>. <small><span class="math inline">\(k=log(1.25)/0.25\approx 0.8926\)</span></small>.
</dd>
</dl>
</dd>
<dt><span id="LU"><em>L</em>, <em>U</em></span></dt>
<dd><dl>
<dt>ABEL, RSABE</dt>
<dd><strong><a href="#abel">ABEL</a></strong>: Lower and upper expanded limits.
<ul>
<li>
30% &lt; <em>CV<sub>wR</sub></em> ≤ 50%: Based on <small><span class="math inline">\(s_{wR}\)</span></small>. <small><span class="math inline">\(\left[ {L,\,U} \right] = 100{e^{ \mp 0.760 \cdot {s_{wR}}}}\)</span></small>
</li>
<li>
<em>CV<sub>wR</sub></em> &gt; <a href="#CVcap">CV<sub>cap</sub></a>: Applying <small><span class="math inline">\(s^*_{wR}=\sqrt{log(CV_{cap}^{2}+1)}\)</span></small> in the expansion formula: <small><span class="math inline">\(\left[ {L,\,U} \right] = {69.84 - 143.19\%}\)</span></small>. All jurisdictions except Health Canada, where <small><span class="math inline">\(\left[ {L,\,U} \right] = {66.7 - 150.0\%}\)</span></small>.
</li>
</ul>
</dd>
<dd><strong><a href="#rsabe">RSABE</a></strong>: Lower and upper ‘implied limits’.
<ul>
<li>
If <small><span class="math inline">\(s_{wR}\geq 0.294\)</span></small>: <small><span class="math inline">\(\left[ {L,\: U} \right] = 100{e^{ \mp 0.8926 \cdot {s_{wR}}}}\)</span></small>
</li>
</ul>
</dd>
</dl>
</dd>
<dd><dl>
<dt>Dose-Proportionality</dt>
<dd><p><small><span class="math inline">\(\left[ {L,\,U} \right]=\left[1+log(0.80)/log(rd),\:1+log(1.25)/log(rd) \right]\)</span></small></p>
</dd>
</dl>
</dd>
<dt>margin</dt>
<dd><dl>
<dt>Non-inferiority/-superiority margin <span style="font-weight:normal">(example for <code>logscale=TRUE</code> where <small><span class="math inline">\(\theta_0=\mu_T/\mu_R\)</span></small>).</span></dt>
<dd><p><strong>Non-inferiority</strong>: If margin &lt; 1, <u>higher</u> responses are are assumed to be better. <small><span class="math display">\[H_0:\,\theta_0 \leq \log({margin})\:vs\:H_1:\,\theta_0&gt;\log({margin})\]</span></small></p>
</dd>
<dd><strong>Non-superiority</strong>: If margin &gt; 1, <u>lower</u> responses are are assumed to be better. <small><span class="math display">\[H_0:\,\theta_0 \geq \log({margin})\:vs\:H_1:\,\theta_0&lt;\log({margin})\]</span></small>
</dd>
</dl>
</dd>
<dt><em>n</em></dt>
<dd>(Total) number of subjects.
</dd>
<dt><em>n<sub>seq</sub></em></dt>
<dd>Number of sequences.
</dd>
<dt><span id="ntid">NTID</span></dt>
<dd>Narrow therapeutic index drug, <em>i.e.</em>, with a steep dose-response curve.
</dd>
<dt><span class="math inline">\(\pi\)</span></dt>
<dd>Target (or desired) power in study planning. Commonly set to 0.80–0.90. In the functions <code>targetpower</code>.
</dd>
<dt>R</dt>
<dd>Reference (treatment, product).
</dd>
<dt><em>rd</em></dt>
<dd>Ratio of the highest/lowest dose. In the functions <code>rd</code>.
</dd>
<dt><code>robust</code></dt>
<dd>Selects degrees of freedom according to Senn’s basic estimator, where <em>n</em> – <em>n<sub>seq</sub></em>.
</dd>
<dt><span id="rsabe">RSABE</span></dt>
<dd>Reference-scaled Average Bioequivalence (U.S. <span title="Food and Drug Administration">FDA</span>, China <span title="National Medical Products Administration, Center for Drug Evaluation">NMPA-CDE</span>). Applicable if the intra-subject variability of the reference treatment <em>s<sub>wR</sub></em> ≥0.294 (<em>CV<sub>wR</sub></em> ≈ 30%). The linearized model is <small><span class="math display">\[H_0:(\mu_T/\mu_R)^2-\theta_{s}^{2}\cdot s_{wR}^{2}&gt;0\:vs\:H_1:(\mu_T/\mu_R)^2-\theta_{s}^{2}\cdot s_{wR}^{2}\leq 0\]</span></small> See also <a href="#abel">ABEL</a>.
</dd>
<dt><span class="math inline">\(\theta_0\)</span></dt>
<dd>Assumed or true T/R-ratio (<code>logscale=TRUE</code>) or difference T–R (<code>logscale=FALSE</code>). In the functions <code>theta0</code>.
</dd>
<dt><span class="math inline">\(\theta_1,\theta_2\)</span></dt>
<dd>Lower and upper limits of the equivalence range. In the functions <code>theta1</code> and <code>theta2</code>.
</dd>
<dt><span class="math inline">\(\theta_s\)</span></dt>
<dd>Regulatory constant in reference-scaling (see also <strong><em><a href="#k">k</a></em></strong>).
</dd>
<dt>T</dt>
<dd>Test (treatment, product).
</dd>
<dt>TIE <span style="font-weight:normal">(type I error)</span></dt>
<dd>Probability that the Null-hypothesis of inequivalence is <em>falsely</em> rejected (<em>i.e.</em>, equivalence is concluded). Also the patient’s risk. Can be assessed with the power-functions setting <code>theta0=theta2</code> or <code>theta0=theta1</code>.<br>Exact, except in reference-scaling based on simulations (<code>power.scABEL()</code>, <code>power.RSABE()</code>, <code>power.NTIDFDA()</code>, <code>power.HVNTID()</code>).
</dd>
</dl>
</div>
<div id="installation" class="section level1">
<h1>Installation</h1>
<p>You can install the released version of PowerTOST from <a href="https://CRAN.R-project.org">CRAN</a> with …</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1">package &lt;-<span class="st"> &quot;PowerTOST&quot;</span></a>
<a class="sourceLine" id="cb1-2" title="2">inst    &lt;-<span class="st"> </span>package <span class="op">%in%</span><span class="st"> </span><span class="kw">installed.packages</span>()</a>
<a class="sourceLine" id="cb1-3" title="3"><span class="cf">if</span> (<span class="kw">length</span>(package[<span class="op">!</span>inst]) <span class="op">&gt;</span><span class="st"> </span><span class="dv">0</span>) <span class="kw">install.packages</span>(package[<span class="op">!</span>inst])</a></code></pre></div>
<p>… and the development version from <a href="https://github.com/">GitHub</a> with</p>
<pre><code># install.packages(&quot;remotes&quot;)
remotes::install_github(&quot;Detlew/PowerTOST&quot;)</code></pre>
<p>Skips installation from a github remote if the <a href="https://en.wikipedia.org/wiki/SHA-1">SHA-1</a> has not changed since last install. Use <code>force = TRUE</code> to force installation.</p>
</div>
<div id="contr" class="section level1">
<h1>Contributors</h1>
<ul>
<li>Detlew Labes (author, maintainer)</li>
<li>Helmut Schütz (author)</li>
<li>Benjamin Lang (author)</li>
</ul>
</div>
<div id="session-information" class="section level1">
<h1>Session Information</h1>
<p>Inspect this information for reproducibility. Of particular importance are the versions of R and the packages used to create this workflow. It is considered good practice to record this information with every analysis.</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb3-1" title="1"><span class="kw">options</span>(<span class="dt">width =</span> <span class="dv">80</span>)</a>
<a class="sourceLine" id="cb3-2" title="2">devtools<span class="op">::</span><span class="kw">session_info</span>()</a>
<a class="sourceLine" id="cb3-3" title="3"><span class="co"># - Session info ---------------------------------------------------------------</span></a>
<a class="sourceLine" id="cb3-4" title="4"><span class="co">#  setting  value                       </span></a>
<a class="sourceLine" id="cb3-5" title="5"><span class="co">#  version  R version 3.6.1 (2019-07-05)</span></a>
<a class="sourceLine" id="cb3-6" title="6"><span class="co">#  os       Windows 7 x64 SP 1          </span></a>
<a class="sourceLine" id="cb3-7" title="7"><span class="co">#  system   x86_64, mingw32             </span></a>
<a class="sourceLine" id="cb3-8" title="8"><span class="co">#  ui       RTerm                       </span></a>
<a class="sourceLine" id="cb3-9" title="9"><span class="co">#  language EN                          </span></a>
<a class="sourceLine" id="cb3-10" title="10"><span class="co">#  collate  German_Germany.1252         </span></a>
<a class="sourceLine" id="cb3-11" title="11"><span class="co">#  ctype    German_Germany.1252         </span></a>
<a class="sourceLine" id="cb3-12" title="12"><span class="co">#  tz       Europe/Vienna               </span></a>
<a class="sourceLine" id="cb3-13" title="13"><span class="co">#  date     2019-10-21                  </span></a>
<a class="sourceLine" id="cb3-14" title="14"><span class="co"># </span></a>
<a class="sourceLine" id="cb3-15" title="15"><span class="co"># - Packages -------------------------------------------------------------------</span></a>
<a class="sourceLine" id="cb3-16" title="16"><span class="co">#  package     * version date       lib source        </span></a>
<a class="sourceLine" id="cb3-17" title="17"><span class="co">#  assertthat    0.2.1   2019-03-21 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-18" title="18"><span class="co">#  backports     1.1.5   2019-10-02 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-19" title="19"><span class="co">#  callr         3.3.2   2019-09-22 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-20" title="20"><span class="co">#  cli           1.1.0   2019-03-19 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-21" title="21"><span class="co">#  crayon        1.3.4   2017-09-16 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-22" title="22"><span class="co">#  desc          1.2.0   2018-05-01 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-23" title="23"><span class="co">#  devtools      2.2.1   2019-09-24 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-24" title="24"><span class="co">#  digest        0.6.21  2019-09-20 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-25" title="25"><span class="co">#  ellipsis      0.3.0   2019-09-20 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-26" title="26"><span class="co">#  evaluate      0.14    2019-05-28 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-27" title="27"><span class="co">#  fs            1.3.1   2019-05-06 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-28" title="28"><span class="co">#  glue          1.3.1   2019-03-12 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-29" title="29"><span class="co">#  htmltools     0.4.0   2019-10-04 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-30" title="30"><span class="co">#  knitr         1.25    2019-09-18 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-31" title="31"><span class="co">#  magrittr      1.5     2014-11-22 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-32" title="32"><span class="co">#  memoise       1.1.0   2017-04-21 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-33" title="33"><span class="co">#  pkgbuild      1.0.6   2019-10-09 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-34" title="34"><span class="co">#  pkgload       1.0.2   2018-10-29 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-35" title="35"><span class="co">#  prettyunits   1.0.2   2015-07-13 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-36" title="36"><span class="co">#  processx      3.4.1   2019-07-18 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-37" title="37"><span class="co">#  ps            1.3.0   2018-12-21 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-38" title="38"><span class="co">#  R6            2.4.0   2019-02-14 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-39" title="39"><span class="co">#  Rcpp          1.0.2   2019-07-25 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-40" title="40"><span class="co">#  remotes       2.1.0   2019-06-24 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-41" title="41"><span class="co">#  rlang         0.4.0   2019-06-25 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-42" title="42"><span class="co">#  rmarkdown     1.16    2019-10-01 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-43" title="43"><span class="co">#  rprojroot     1.3-2   2018-01-03 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-44" title="44"><span class="co">#  sessioninfo   1.1.1   2018-11-05 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-45" title="45"><span class="co">#  stringi       1.4.3   2019-03-12 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-46" title="46"><span class="co">#  stringr       1.4.0   2019-02-10 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-47" title="47"><span class="co">#  testthat      2.2.1   2019-07-25 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-48" title="48"><span class="co">#  usethis       1.5.1   2019-07-04 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-49" title="49"><span class="co">#  withr         2.1.2   2018-03-15 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-50" title="50"><span class="co">#  xfun          0.10    2019-10-01 [1] CRAN (R 3.6.1)</span></a>
<a class="sourceLine" id="cb3-51" title="51"><span class="co">#  yaml          2.2.0   2018-07-25 [1] CRAN (R 3.6.0)</span></a>
<a class="sourceLine" id="cb3-52" title="52"><span class="co"># </span></a>
<a class="sourceLine" id="cb3-53" title="53"><span class="co"># [1] D:/Program Files/R/R-3.6.1/library</span></a></code></pre></div></div>
<div id="license" class="section level1">
<h1>License</h1>
<h4 class="author">Helmut Schütz 2019-10-21</h4>
<p><a href="https://cran.r-project.org/web/licenses/GPL-2" title="GNU General Public License, Version 2">GPL-2</a> | <a href="https://cran.r-project.org/web/licenses/GPL-3" title="GNU General Public License, Version 3">GPL-3</a></p>
</div>
<!-- code folding -->
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>
</html>
